Search - tctmd.com

Displaying 341 - 360 of 743

Sort: Relevancy | Date

Presentation iASSESS 2017

Femoral Access and Related Complications

Presenter: Arnold Seto

August 30, 2017

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

August 30, 2017

Presentation iASSESS 2017

Complications of Structural Heart Disease Intervention - Part 1

Presenter: George Hanzel

August 30, 2017

Podcast Heart Sounds

Guidelines for the Management of Valvular Heart Disease

Presenter: Helmut Baumgartner

August 29, 2017

Presentation ESC 2017

The Viborg Vascular (VIVA) Randomised Screening Trial

Presenter: Jes Lindholt

August 29, 2017

News Conference News ESC 2017

P2Y12 Inhibitor Pretreatment Questioned in STEMI

Todd Neale

August 29, 2017

News Conference News ESC 2017

VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost?

Shelley Wood

August 28, 2017

News Conference News ESC 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Shelley Wood

August 27, 2017

News Daily News

Hypertension, Underuse of Beta-Blockers Linked to Recurrent Tear in SCAD Patients

L.A. McKeown

August 24, 2017

News Daily News

After Failed Mitral Valve Surgery, Transcatheter Valve-in-Valve or Valve-in-Ring Shows Promise in High-Risk Patients

Yael L. Maxwell

August 24, 2017

News Daily News

TAVR in the US: Regional Variations in Numbers, Outcomes

Michael O'Riordan

August 22, 2017

Presentation

Regional Variation in Utilization, In-Hospital Mortality, and Resource Use of TAVR in US

August 22, 2017

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

News Daily News

FDA: Class I Recall for Cook’s Thoracic Endovascular Grafts

Michael O'Riordan

August 17, 2017

News Daily News

Off-Pump CABG Linked to Higher Long-term Mortality in ROOBY-FS

L.A. McKeown

August 16, 2017

Podcast

Episode 16: Healthcare Reform, Embolic Protection in TAVR, and More

August 10, 2017

Presentation

Optimized Screening of CAD With Invasive Coronary Angiography and Ad Hoc PCI During TAVR

August 10, 2017

News Daily News

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Leah Lawrence

August 10, 2017

News Daily News

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

Ashley Lyles

August 08, 2017

Advertisement

Femoral Access and Related Complications

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

Complications of Structural Heart Disease Intervention - Part 1

Top Stories in Cardiology, August 2017

Guidelines for the Management of Valvular Heart Disease

The Viborg Vascular (VIVA) Randomised Screening Trial

P2Y12 Inhibitor Pretreatment Questioned in STEMI

VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost?

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Hypertension, Underuse of Beta-Blockers Linked to Recurrent Tear in SCAD Patients

After Failed Mitral Valve Surgery, Transcatheter Valve-in-Valve or Valve-in-Ring Shows Promise in High-Risk Patients

TAVR in the US: Regional Variations in Numbers, Outcomes

Regional Variation in Utilization, In-Hospital Mortality, and Resource Use of TAVR in US

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

FDA: Class I Recall for Cook’s Thoracic Endovascular Grafts

Off-Pump CABG Linked to Higher Long-term Mortality in ROOBY-FS

Episode 16: Healthcare Reform, Embolic Protection in TAVR, and More

Optimized Screening of CAD With Invasive Coronary Angiography and Ad Hoc PCI During TAVR

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content